Tempo Therapeutics

Tempo Therapeutics is a privately held clinical-stage technology company pioneering the future of tissue engineering. The company leverages its patented Microsphere-Annealed Particle (MAP) technology platform to develop novel synthetic biomaterials for various surgical reconstruction and therapeutic regenerative applications, transforming the landscape of medical technology through the power of immunomodulation and materials science.